Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-02-13 @ 3:38 PM
Study NCT ID:
NCT07197957
Status:
RECRUITING
Last Update Posted:
2025-09-30
First Post:
2025-09-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
Sponsor:
BayCare Health System
Organization:
Study Overview
Official Title:
Clinical Utility of Cystatin C in the Early Detection of Contrast Induced Acute Kidney Injury
Status:
RECRUITING
Status Verified Date:
2025-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Detailed Description:
The primary objective of this study is to evaluate the clinical utility of Cystatin C in early detection of contrast-induced AKI.
To evaluate the effect of patient characteristics in the Cystatin C based GFR estimation in comparison to Cr based estimation.
To evaluate the effect of patient characteristics in the Cystatin C based GFR estimation in comparison to Cr based estimation.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: